A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
Recruiting now · Phase 3
Conditions studied: Anemia Due to Chronic Kidney Disease
In brief
This is a phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in anemic patients with End-Stage-Kidney-Disease (ESKD)
Key facts
- Study ID
- NCT07494409
- Run by
- Kind Pharmaceuticals LLC
- People needed
- 300
- Starts
- 2025-10-31
- Expected to finish
- 2027-04-30
- Last updated by the study team
- 2026-03-27
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Fudan Univeristy Zhongshan Hospital — Shanghai, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.